Everolimus and Z-e syndrome - a phase IV clinical study of FDA data
We study 12,722 people who have side effects when taking Everolimus. Z-e syndrome is found, especially among people who are male, 30-39 old and have Neuroendocrine tumor.
The phase IV clinical study analyzes which people take Everolimus and have Z-e syndrome. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
12,722 people reported to have side effects when taking Everolimus.
Among them, 2 people (0.02%) have Z-e syndrome.
What is Everolimus?
Everolimus has active ingredients of everolimus. Currently, eHealthMe is studying from 14,700 Everolimus users.
What is Z-e syndrome?
Z-e syndrome (increased production of the hormone gastrin from a small tumour of pancreas) is found to be associated with 148 drugs and 173 conditions by eHealthMe. Currently, we are studying 1,239 people who have Z-e syndrome.
Number of Everolimus and Z-e syndrome reports submitted per year:
Gender of people who have Z-e syndrome when taking Everolimus *:
- female: 0.0 %
- male: 100 %
Age of people who have Z-e syndrome when taking Everolimus *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 100 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 0.0 %
Common side effects people have besides Z-e syndrome *:
- Diarrhea: 2 people, 100.00%
- Weight Decreased: 1 person, 50.00%
- Hepatic Lesion: 1 person, 50.00%
- Abdominal Pain: 1 person, 50.00%
- Blood Gastrin Increased: 1 person, 50.00%
- Cholecystitis (infection of gallbladder): 1 person, 50.00%
- Dehydration (dryness resulting from the removal of water): 1 person, 50.00%
- Drug Intolerance (drug sensitivity): 1 person, 50.00%
- Gallstones (stone formation by bile component): 1 person, 50.00%
- Haemoglobin Decreased: 1 person, 50.00%
Common conditions people have *:
- Neuroendocrine Tumor: 1 person, 50.00%
* Approximation only. Some reports may have incomplete information.
Do you take Everolimus and have Z-e syndrome?Check whether Z-e syndrome is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Everolimus side effects by duration, gender and age:
- Everolimus side effects (14,700 reports)
Z-e syndrome treatments and more:
- Z-e syndrome (1,239 reports)
All the drugs that are associated with Z-e syndrome:
- Z-e syndrome (148 drugs)
All the conditions that are associated with Z-e syndrome:
- Z-e syndrome (173 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on everolimus (the active ingredients of Everolimus) and Everolimus (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Solu-Cortef and Oedema Peripheral - 3 seconds ago
- Effexor and Thyroid Gland Removal - 4 seconds ago
- Bumetanide and Actiq drug interaction - 6 seconds ago
- Ropivacaine Hydrochloride and Dizziness - 9 seconds ago
- Fentanyl and Epicondylitis - 9 seconds ago
- Inderal and Monistat 3 drug interaction - 12 seconds ago
- Albuterol Sulfate and Naltrexone Hydrochloride drug interaction - 15 seconds ago
- Pomalyst and Ibandronate Sodium drug interaction - 16 seconds ago
- Lumigan and Ultracet drug interaction - 23 seconds ago
- Lamisil and Neutropenia Aggravated - 27 seconds ago